Meeting
2023 ASCO Annual Meeting
A study of tumor neoantigen burden and HLA-LOH by whole-exome sequencing to characterize immune biomarkers of lung cancer.
Authors
Wei Wang
Department of Thoracic Surgery, Renmin Hospital of Wuhan University, Wuhan, China
Wei Wang , Wenting Liao , Baoling Zhen , Tianrong Ji , Chen Du , Shaochen Cheng , Yaru Chen , Jie Yang
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers
Track
Lung Cancer
Sub Track
Adjuvant Therapy
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 8527)
DOI
10.1200/JCO.2023.41.16_suppl.8527
Abstract #
8527
Poster Bd #
154
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Annual Meeting
Pan-cancer B- and T-cell transcriptome analysis of CXCL13 as a predictive marker for immune checkpoint inhibitor response.
First Author: Yu Fujiwara
Poster
2024 ASCO Annual Meeting
Fasting mimicking diet reduces anti-OX40/anti PD-L1 and anti-PD-1/anti-CTLA-4 cardiovascular side effects in preclinical melanoma models.
First Author: Vincenzo Quagliariello
First Author: Michelle Wedemeyer
Poster
2022 ASCO Annual Meeting
Micro-organospheres retain patient tumor microenvironment for precision immuno-oncology.
First Author: Shengli Ding